Genetic and environmental regulation of Na/K adenosine triphosphatase activity in diabetic patients

Metabolism: Clinical and Experimental

Volumn 51, Issue 3, 2002, Pages 284-291

  Jannot, M F ^a   Raccah, D ^a   De La Tour, D Dufayet ^a   Coste, T ^a   Vague, P ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) ALPHA 1; C PEPTIDE; HEMOGLOBIN A1C; INSULIN; ISOENZYME; ORAL ANTIDIABETIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ERYTHROCYTE; ETHNIC DIFFERENCE; EUROPE; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC REGULATION; GENETIC RISK; HETEROZYGOSITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORTH AFRICA; PATHOGENESIS; POPULATION DYNAMICS; PREVALENCE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION SITE;

EID: 0036123533     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.29009     Document Type: Article

References (65)

1. Molecular genetic of NaK ATPase
2. + ATPase alpha subunit gene is expressed in testis
3. Characterization of the fourth alpha isoform of the Na/K ATPase
4. Identification of a putative isoform of the Na/K ATPase beta subunit. Primary structure and tissue-specific expression
5. Identification of the mammalian Na/K ATPase beta 3 subunit
6. + ATPase in schwann cells: Adhesion molecules and nerve regeneration
7. NaK ATPase in dog red cells
8. The human Na/K ATPase alpha 1 gene: Characterization of the 5′-flanking region and identification of a restriction fragment length polymorphism
9. + ATPase activity in type 1 (insulin dependent) diabetic subjects and its activation by homologous plasma
10. Hypothesis low Na/K ATPase activities of the red cell membrane, a potential marker of the predisposition to diabetic neuropathy
11. Erythrocyte NaK ATPase activity, metabolic control and neuropathy in insulin dependent diabetic patients
12. Effect of experimental diabetes on NaK ATPase activity in red blood cells, peripheral nerve and kidney
13. + ATPase activity in the pathogenesis of human diabetic neuropathy
14. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. Relationship between protein kinase C and ATPases
15. Alteration of Na/K ATPase isoenzymes in diabetic cardiomyopathy effect of dietary supplementation with fish oil (n-3 fatty acid) in rats
16. Sorbitol, phosphoinositides, and sodium potassium-ATPase in the pathogenesis of diabetic complications
17. Experimental diabetic neuropathy: An update
18. Increased prevalence of neurologic complications among insulin dependent diabetic patients of algerian origin
19. +) adenosine triphosphatase
20. Sodium-Potassium ATPase activity is influenced by ethnic origin and not by obesity
21. Association of diabetic neuropathy with Na/K ATPase gene polymorphism
22. Diabetic peripheral neuropathy: Effects of age, duration of diabetes, glycemic control, and vascular factors
23. Erythrocyte Na/K ATPase activity and diabetes: Relationship with c-peptide level
24. + ATPase activity of renal tubule segments
25. +-ATPase activity in diabetes mellitus type 1
26. Natural history of peripheral neuropathy in patients with non-insulino-dependent diabetes mellitus
27. Factors in the development of diabetic neuropathy. Baseline analysis of neuropathy in feasability phase of diabetic control and complications trials
28. The removal of leukocytes and platelets from whole blood
29. In vivo insulin effect on ATPase activities in erythrocyte membrane from insulin-dependent diabetics
30. Primary structure of the alpha subunit of human Na/K ATPase deduced from cDNA sequence
31. Na/K ATPase
32. Subunit assembly and functional maturation of NaK ATPase
33. +
34. + pump activity in cultured neuroblastoma cells
35. + pump activity in cultured neuroblastoma cells by normalizing glucose levels
36. Na/K ATPase activity in type 2 (non insulin dependent) diabetic patients with microalbuminuria
37. Changes in NA K adenosine triphosphatase (ATPase) concentration and Na/K ATPase-dependent adenosine triphosphate turn over in human erythrocytes in diabetes
38. +-ATPase in diabetes related to insulin, starvation, and training
39. Hormonal regulation of the Na/K ATPase: Mechanism underlying rapid and sustained changes in pump activity
40. Insulin and glucagon stimulation of (Na+, K+) ATPase transport activity in isolated rat hepatocytes
41. + ATPase by insulin: Why and how?
42. Membrane electrical properties associated with insulin receptor down regulation in human erythrocytes
43. +) ATPase
44. + ATPase pump by insulin
45. Insulin enhances sodium sensitivity of Na-K-ATPase in isolated rat proximal convoluted tubule
46. + ATPase from intracellular compartments to the plasma membrane in mammalian skeletal muscle
47. + ATPase subunits to the plasma membrane in muscle fiber type specific
48. + ATPase subunits in transgenic mice overexpressing the GLUT4 glucose transporter
49. Role of protein kinase C in insulin activation of the NaK pump in cultured skeletal muscle
50. + uptake in 3T3-L1 fibroblasts involves phosphatidylinositol 3-kinase and protein kinase C-zeta
51. Specific binding of pro-insulin C-peptide to human cell membranes
52. New aspects on biological activity of C-peptide in IDDM patients
53. Does C-peptide have a physiological role?
54. Role of C-peptide in human physiology
55. Renal and splanchnic exchange of human biosynthetic C peptide in type 1 (insulin dependent) diabetes mellitus
56. The influence of human C-peptide on renal function and glucose utilization in diabetes type 1 (insulin-dependent) diabetic patients
57. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus
58. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide
59. Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients
60. Effect of human C-peptide on glucose transport in vitro incubated human skeletal muscle
61. New aspects of C-peptide physiology
62. C-peptide improves autonomic nerve function in IDDM patients
63. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with type 1 diabetes mellitus
64. Modulation of insulin receptor signalling: Significance of altered receptor isoform patterns and mechanism of hyperglycemia-induced receptor modulation
65. DNA variation in the genes of the Na/K ATPase and its relation with resting metabolic rate, respiratory quotient and body fat